MedTrace Logo

Impact of Boostrix™ Maternal Vaccination on Morbidity and Mortality of Pertussis Disease in Infants ≤6 Weeks of Age, in Bogota, Colombia.

NCT02569879 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2024-02-22

No results posted yet for this study

Summary

This study is being conducted to assess impact of maternal immunisation against pertussis in infants ≤12 months of age before and after introduction of pertussis maternal immunisation in Bogota, Colombia from January 2005-December 2014.

Conditions

  • Diphtheria
  • Acellular Pertussis
  • Tetanus
  • Aspergillosis, Allergic Bronchopulmonary
  • Diphtheria-Tetanus-acellular Pertussis Vaccines

Interventions

OTHER

Pertussis maternal immunization

Retrospective time trend analysis before and after pertussis maternal immunization in Bogota, Colombia.

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Min Age
0 Days
Max Age
12 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-01
Primary Completion
2018-04-14
Completion
2018-04-14

Countries

  • Colombia

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02569879 on ClinicalTrials.gov